If you have a significantly leaking mitral valve and have been told that open-heart surgery would be too risky, you may have heard about a procedure called MitraClip, or more generally transcatheter edge-to-edge repair (TEER). It is one of the most important developments in structural heart disease over the past decade, because it gives patients who were once out of options a way to treat their valve without opening the chest. This guide explains what TEER is, who it helps, and how to think about it alongside traditional surgery.
Understanding Mitral Regurgitation
The mitral valve sits between the two chambers on the left side of the heart. With every heartbeat it should open to let blood flow forward and then close tightly to keep blood from washing backward. When the valve does not seal properly, blood leaks back into the upper chamber. This is called mitral regurgitation. A severe leak forces the heart to work harder, can enlarge and weaken the heart over time, and produces symptoms such as shortness of breath, fatigue, swelling, and reduced ability to exert yourself.
There are two broad types, and the distinction matters a great deal for treatment. Primary (or degenerative) mitral regurgitation is caused by a problem with the valve itself, such as a leaflet that has become floppy or a torn supporting cord. Secondary (or functional) mitral regurgitation is caused by disease of the heart muscle that stretches the valve out of shape, even though the valve leaflets themselves are relatively normal. The best treatment, and whether TEER is appropriate at all, depends on which type you have. This is one reason a careful, independent cardiac second opinion can be so useful before committing to a procedure.
How Transcatheter Edge-to-Edge Repair Works
The principle behind TEER is elegant. Rather than removing or rebuilding the valve, the procedure clips the leaking leaflets together at one or more points. By grasping the edges of the two mitral leaflets and holding them together, the device creates a double opening that allows blood to flow forward while greatly reducing the backward leak.
The procedure is performed by a structural cardiologist, not through the chest, but through a vein in the leg. A thin catheter is guided up to the heart, and the device is positioned and deployed under the guidance of advanced imaging, including a transesophageal echocardiogram performed during the procedure. Because there is no surgical incision in the chest and no heart-lung machine, recovery is much faster than after open surgery. Most patients stay in the hospital only a day or two and return to normal activity within a week or two.
Who Is a Candidate?
TEER is not a replacement for surgery in every patient. For younger, healthier patients with primary mitral regurgitation, surgical repair remains the gold standard and offers the most durable result. TEER was developed, and is most clearly beneficial, for patients who are at high or prohibitive risk for surgery, whether because of advanced age, weakened heart function, prior heart surgery, or other serious medical conditions.
Candidacy also depends on the precise anatomy of your valve. The leaflets must be suitable for the device to grasp, and the imaging team studies this in detail before recommending the procedure. For patients with secondary mitral regurgitation due to a weakened heart, TEER can reduce symptoms and improve outcomes in carefully selected cases, but only when the heart failure has already been treated with optimal medications first. Sorting out whether you fit these criteria is exactly the kind of judgment that benefits from a second set of expert eyes. Understanding your own surgical risk is part of that picture, and our cardiac risk calculator can help you see where you stand.
TEER Compared to Surgery
It helps to think about TEER and surgery as complementary rather than competing. Each is the right answer for different patients.
- Durability: Surgical repair, when feasible, generally produces the most complete and lasting correction of the leak, especially for primary mitral regurgitation. TEER reduces the leak effectively but may leave some residual leak, and some patients later need additional treatment.
- Risk and recovery: TEER avoids open-heart surgery entirely, which is its central advantage for high-risk patients. Recovery is faster, the hospital stay is shorter, and there is no chest incision to heal.
- Candidacy: Surgery can address a wider range of valve problems and is often preferred in lower-risk patients. TEER depends on favorable valve anatomy and is best suited to those for whom surgery carries high risk.
The decision is rarely black and white, and it should be made by a team that includes both an interventional cardiologist and a cardiac surgeon evaluating your case together. When a recommendation comes from a center that performs only one type of procedure, it is reasonable to ask whether the full range of options was considered. An independent dual-physician review can answer exactly that question.
Recovery and What to Expect Afterward
One of the most appealing aspects of TEER for patients and families is the recovery. Because there is no chest incision and no heart-lung machine, most people experience far less discomfort than after open surgery and return to their usual routines quickly. The most common site of soreness is the small puncture in the leg where the catheter was inserted, which heals within days. Many patients notice an improvement in their breathing and energy within the first few weeks as the heart adjusts to the reduced leak.
After the procedure, your team will typically prescribe medications to reduce the small risk of a clot forming on the new device, and you will have follow-up echocardiograms to confirm that the leak remains controlled. It is important to keep these appointments, because they tell your team whether the result is holding and whether any additional treatment may be helpful over time. As with any procedure, TEER carries some risks, including bleeding, clot formation, or the possibility that the device does not reduce the leak as much as hoped. These risks are generally low in experienced centers, but they are real, which is another reason the experience of the team performing the procedure genuinely matters.
It also helps to set realistic expectations about the goal of TEER in high-risk patients. For many, the aim is not a perfect, leak-free valve but a meaningful reduction in the leak that relieves symptoms and improves quality of life. Understanding that distinction in advance helps patients and families judge the result fairly and feel satisfied with a procedure that achieves exactly what it was designed to do.
Making an Informed Choice
A leaking mitral valve is a serious condition, but it is also a very treatable one, and patients today have more options than ever. The challenge is matching the right option to the right patient. That depends on the type of leak, the condition of your heart muscle, your valve's specific anatomy, your surgical risk, and your own goals and preferences.
At WhiteGloveMD, every case is reviewed by a cardiologist and a cardiac surgeon together as a dual-physician Heart Team. We review your actual echocardiogram and records, assess whether TEER, surgical repair, surgical replacement, or continued medical therapy best fits your situation, and explain the reasoning clearly. You can see how our review works before deciding anything.
If you are considering MitraClip or weighing it against surgery, an independent review can bring real clarity. Our Heart Team reviews start From $500, with a 24-hour review after your records are received. Request a call to discuss your case, or review our pricing and packages to choose the right option for you.